Journal of Clinical Oncology, Vol 26, No 5 (February 10), 2008: pp. 786-790
© 2008 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2008.15.0243
Locally Advanced and Inflammatory Breast Cancer
Stephen Chia, Sandra M. Swain, David R. Byrd, and David A. Mankoff
You have reached the most complete version of this article accessible without further authentication.
More complete versions are available.
Link to article
|
Article topics:
- Oncology..Treatment Options for Breast Cancer
- Medicine..Breast Issues
- Oncology..Detection/Screening and Prognosis of Breast Cancer
- Oncology..Breast Cancer
- Oncology..Surgery
- Oncology..Epidemiology, Causes, and Risk Factors of Breast Cancer
- Oncology..Metastasis
- Oncology..Cancer Surveillance
- Oncology..Incidence
- Oncology..Incidence and Mortality of Breast Cancer
- Oncology..Advanced Breast Cancer
- Oncology..Population-Based Studies
- Oncology..CT Scans
- Oncology..Epidemiology
- Oncology..Diagnosis
- Developmental Biology..Angiogenesis
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Facebook  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
G. Frasci, G. D'Aiuto, P. Comella, M. D'Aiuto, M. Di Bonito, P. Ruffolo, G. Iodice, A. Petrillo, S. Lastoria, P. Oliviero, et al.
Preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) improves prognosis in locally advanced breast cancer patients: an update of the Southern Italy Cooperative Oncology Group (SICOG) randomised trial 9908
Ann. Onc.,
October 8, 2009;
(2009)
mdp356v1.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. M. Sikov, D. S. Dizon, R. Strenger, R. D. Legare, K. P. Theall, T. A. Graves, J. S. Gass, T. A. Kennedy, and M. A. Fenton
Frequent Pathologic Complete Responses in Aggressive Stages II to III Breast Cancers With Every-4-Week Carboplatin and Weekly Paclitaxel With or Without Trastuzumab: A Brown University Oncology Group Study
J. Clin. Oncol.,
October 1, 2009;
27(28):
4693 - 4700.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. H. Lee, E. L. Rosen, and D. A. Mankoff
The Role of Radiotracer Imaging in the Diagnosis and Management of Patients with Breast Cancer: Part 2--Response to Therapy, Other Indications, and Future Directions
J. Nucl. Med.,
May 1, 2009;
50(5):
738 - 748.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. H. Lee, E. L. Rosen, and D. A. Mankoff
The Role of Radiotracer Imaging in the Diagnosis and Management of Patients with Breast Cancer: Part 1--Overview, Detection, and Staging
J. Nucl. Med.,
April 1, 2009;
50(4):
569 - 581.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Molckovsky, B. Fitzgerald, O. Freedman, R. Heisey, and M. Clemons
Approach to inflammatory breast cancer
Can Fam Physician,
January 1, 2009;
55(1):
25 - 31.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. R. Gralow, J. A. Zujewski, and E. Winer
Preoperative Therapy in Invasive Breast Cancer: Reviewing the State of the Science and Exploring New Research Directions
J. Clin. Oncol.,
February 10, 2008;
26(5):
696 - 697.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. R. Gralow, H. J. Burstein, W. Wood, G. N. Hortobagyi, L. Gianni, G. von Minckwitz, A. U. Buzdar, I. E. Smith, W. F. Symmans, B. Singh, et al.
Preoperative Therapy in Invasive Breast Cancer: Pathologic Assessment and Systemic Therapy Issues in Operable Disease
J. Clin. Oncol.,
February 10, 2008;
26(5):
814 - 819.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
